Akanda
Akanda · page 2
- Companies
Akanda Corp Faces Delisting For 2nd Time After Stock Consolidation
AKANDA Corp is under threat of being delisted from NASDAQ for the second time in less than a year, throwing its future as a publicly listed company into question.
- Markets & Stocks
Zelira Stock Triples After Positive Trial Results, Akanda Drops As Loan Agreement Scrapped, & Tikun Olam Cannbit Pulls Out Of Merger Talks
Akanda [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”AKAN” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Akanda has seen its stock drop by nearly 20% this week as news broke that a short-term loan agreement, announced just a month ago, had now been scrapped.
- Markets & Stocks
Akanda’s Stock Price Jumps On Revenue Increase, MGC Pharma Secures EU-GMP At Malta Facility, & Cellular Goods Reports Growing Revenues
Akanda [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”AKAN” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Akanda was one of a number of major European cannabis firms to release financial figures this week, days before announcing that it had secured a new ‘short-term’ $500k loan.
- Companies
European Cannabis Stocks Review: Intercure Breaks Israeli Records In 2022, Chill Brands Rises, & Akanda Could Face Delisting Again
InterCure [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”INCR” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] InterCure has continued its blistering run of financial performance after revealing another record quarter over the weekend, ‘solidifying (its) leading position’ over its Israeli competitors and sending its stock up over 20%.
- Markets & Stocks
European Cannabis Stocks Review: Akanda Implement’s 1-10 Stock Consolidation, IMC Slashes 20% Of Staff, & More From DanCann Pharma
Akanda Akanda has become the latest NASDAQ-listed cannabis company to enact a stock consolidation in order to avoid delisting from the stock exchange.
- Markets & Stocks
Love Hemp Becomes First Cannabis Casualty Of 2023 As It Calls In Administrators & Akanda’s CEO Tej Virk Resigns
Love Hemp BusinessCann has learned that the embattled CBD retailer Love Hemp has officially called in administrators.
- Pharmaceutical
European Cannabis Stocks Review: Akanda Announces ‘First Significant Revenue Above Initial Projections’
Akanda Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not seen since October.
- Pharmaceutical
European Cannabis Stocks Review: Akanda Reports $2.3m Loss From Bophelo, OCT Shares Spike & Cellular Goods Sales Slow
Akanda Akanda unveiled its unaudited financial figures for the six months to the end of June 2022, two weeks after revealing that its CEO has been on ‘paid leave of absence’ since November.
- Markets & Stocks
Akanda Pulls Out Of Lesotho Amid Ongoing Legal Battle, Bruce Linton Joins SynBiotic, & Ananda Completes Acquisition
Akanda The NASDAQ-listed international medical cannabis operator announced last week that it will abandon its operations in Lesotho following a legal battle with a disgruntled former director.
- Markets & Stocks
European Cannabis Stocks Review: DeepVerge Drops 60% As It Warns May Not Have ‘Sufficient Equity’ To Make Loan Repayments
WHILE last week’s news from the US saw many EU cannabis stocks experience a spike in stock price on Friday, these gains were almost unanimously lost within hours.
- Markets & Stocks
European Cannabis Stocks Review: Akanda Becomes Second Cannabis Company In Less Than 6 Months To Face Possible NASDAQ Delisting
NEWS broke yesterday evening that US President Joe Biden has moved to federally pardon thousands of Americans with minor cannabis convictions.
- Press releases
Akanda Plans First Shipment Of Medical Cannabis To Germany And Anticipates Leading Market Share Position
INTERNATIONAL medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) expects to take a leading position in the fast-growing German medical cannabis market, as it prepares for first export shipment from its Portugal-based Holigen operation in the coming weeks.
